Blog

In draft guidance published today healthcare guidance body NICE has recommended ledipasvir-sofosbuvir (Harvoni, Gilead Sciences) as a treatment option for ...

Enzalutamide (trade name: Xtandi) has been approved since December 2014 for men who have metastatic prostate cancer that is not ...

[:content [\1 \5 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \space \A \n \a \l \y \s \i \s \space \o \f \space \t \h \e \space \P \u \b \l \i \c \space \S \u \m \m \a \r \y \space \D \o \c \u \m \e \n \t \s \space \f \r \o \m \space \t \h \e \space \N \o \v \e \m \b \e \r \space \2 \0 \1 \3 \space \P \B \A \C \space \m \e \e \t \i \n \g \space \h \a \s \space \r \e \v \e \a \l \e \d \space \t \h \e \space \C \o \m \m \i \t \t \e \e " ..."]]

[:content [\T \h \e \space \E \u \r \o \p \e \a \n \space \M \e \d \i \c \i \n \e \s \space \A \g \e \n \c \y \space \( \E \M \A \) \space \a \n \d \space \E \U \n \e \t \H \T \A \, \space \t \h \e \space \E \u \r \o \p \e \a \n \space \N \e \t \w \o \r \k \space \f \o \r \space \H \e \a \l \t \h \space \T \e \c \h \n \o \l \o \g \y \space \A \s \s \e \s \s \m \e \n \t \, \space \m \e \t \space \t \o \space \r \e \v \i \e \w \space \t \h \e \space \p \r \o \g \r \e \s \s \space \o \f " ..."]]

If a person needs to take two anti-diabetic drugs, canagliflozin is recommended as a possible treatment for people with type 2 ...

[:content [\D \a \b \r \a \f \e \n \i \b \space \m \e \s \y \l \a \t \e \space \( \T \a \f \i \n \l \a \r \) \space \h \a \s \space \b \e \e \n \space \a \p \p \r \o \v \e \d \space \i \n \space \G \e \r \m \a \n \y \space \s \i \n \c \e \space \A \u \g \u \s \t \space \2 \0 \1 \3 \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f \space \p \a \t \i \e \n \t \s \space \w \i \t \h \  \a \d \v \a \n \c \e \d \space \m \e \l \a \n \o \m \a \. \space \I \n \space \a \n " ..."]]

NICE has issued preliminary draft guidance not recommending sipuleucel-T for prostate cancer in people whose disease has spread, who have ...

PHARMAC will be running a commercial process to fund medicines for rare disorders – a request for proposals (RFP). A ...

The bosses of nine of Australia's largest multinational pharmaceutical companies will appear in front of a Senate committee investigating corporate tax avoidance. ...

The National Institute for Health and Care Excellence has welcomed the announcement of a review to consider patient access to ...

[:content [\1 \0 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \  \  \A \e \g \e \r \i \o \n \space \P \h \a \r \m \a \c \e \u \t \i \c \a \l \s \, \  \a \space \b \i \o \p \h \a \r \m \a \c \e \u \t \i \c \a \l \space \c \o \m \p \a \n \y \space \d \e \d \i \c \a \t \e \d \space \t \o \space \t \h \e \space \d \e \v \e \l \o \p \m \e \n \t \space \a \n \d \space \c \o \m \m \e \r \c \i \a \l \i \z \a \t \i \o \n \space \o \f \space \i \n \n \o \v \a \t \i \v \e \space \t \h \e \r \a \p \i \e \s \space \f \o \r \space \p \a \t \i \e \n \t \s \space \w \i \t \h \space \d \e \b \i \l \i \t \a \t \i \n \g " ..."]]

New findings released by Newspoll shows overwhelming support for access to new cancer medicines through the Pharmaceutical Benefits Scheme (PBS), for ...

Cystic fibrosis (CF) patients and their families are celebrating after the Federal Government listed a drug on the Pharmaceutical Benefits ...

Patients with multiple myeloma are currently unlikely to get ‘routine’ access to Celgene’s Imnovid (pomalidomide) on the National Health Service ...